Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schwander

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|February 15, 1993
[Tongue ulcer in azidothymidine-induced neutropenia. Rapid increase in neutrophils and healing of the ulcer by substitution of recombinant human granulocyte colony stimulating factor (rhG-CSF)]S Schwander, P Kern
Clinical & Developmental Immunology|October 24, 2012
HIV-associated tuberculosis 2012K A Wilkinson, M E Torok, S Schwander, et al.
International Journal of Immunopharmacology|January 1, 1991
Enhancement of monocyte antimycobacterial activity by diethyldithiocarbamate (DTC)L Hübner, M Ernst, D von Laer, et al.
Archives of Virology|January 1, 1991
Progression of HIV-1 infection. Monitoring of HIV-1 DNA in peripheral blood mononuclear cells by PCRF T Hufert, D von Laer, T E Fenner, et al.
The Journal of General Virology|February 1, 1997
Diversity of the vif gene of human immunodeficiency virus type 1 in UgandaU Wieland, A Seelhoff, A Hofmann, et al.
Journal of Medical Virology|February 1, 1992
Prevalence of antibodies to recombinant virion infectivity factor in the sera of prospectively studied patients with HIV-1 infectionS Schwander, R W Braun, J E Kühn, et al.
Blood|October 1, 1990
CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virusD von Laer, F T Hufert, T E Fenner, et al.
Infection|March 1, 1994
Phase I/II vaccination study of recombinant peptide F46 corresponding to the HIV-1 transmembrane protein coupled with 2.4 dinitrophenyl (DNP) FicollS Schwander, M Opravil, R Lüthy, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 1, 1995
A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosisS Schwander, S Rüsch-Gerdes, A Mateega, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study GroupA Chiesi, S Vella, L G Dally, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Medizinische Klinik (Munich, Germany : 1983)|February 15, 1993
[Tongue ulcer in azidothymidine-induced neutropenia. Rapid increase in neutrophils and healing of the ulcer by substitution of recombinant human granulocyte colony stimulating factor (rhG-CSF)]S Schwander, P Kern
Clinical & Developmental Immunology|October 24, 2012
HIV-associated tuberculosis 2012K A Wilkinson, M E Torok, S Schwander, et al.
International Journal of Immunopharmacology|January 1, 1991
Enhancement of monocyte antimycobacterial activity by diethyldithiocarbamate (DTC)L Hübner, M Ernst, D von Laer, et al.
Archives of Virology|January 1, 1991
Progression of HIV-1 infection. Monitoring of HIV-1 DNA in peripheral blood mononuclear cells by PCRF T Hufert, D von Laer, T E Fenner, et al.
The Journal of General Virology|February 1, 1997
Diversity of the vif gene of human immunodeficiency virus type 1 in UgandaU Wieland, A Seelhoff, A Hofmann, et al.
Journal of Medical Virology|February 1, 1992
Prevalence of antibodies to recombinant virion infectivity factor in the sera of prospectively studied patients with HIV-1 infectionS Schwander, R W Braun, J E Kühn, et al.
Blood|October 1, 1990
CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virusD von Laer, F T Hufert, T E Fenner, et al.
Infection|March 1, 1994
Phase I/II vaccination study of recombinant peptide F46 corresponding to the HIV-1 transmembrane protein coupled with 2.4 dinitrophenyl (DNP) FicollS Schwander, M Opravil, R Lüthy, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 1, 1995
A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosisS Schwander, S Rüsch-Gerdes, A Mateega, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study GroupA Chiesi, S Vella, L G Dally, et al.
Pageof 2